UAE Patient Adherence and Support Programs
Each patient journey is unique and requires the creation of a customized support plan that comprehensively addresses the unmet needs and challenges of the patient in a personalized manner.
The World Health Organization (WHO) reports chronic diseases are by far the leading cause of mortality globally, representing 60% of all deaths (approximately 35 million people per annum). Patient adherence to long-term treatment for chronic diseases is a problem worldwide of striking magnitude, averaging 50% in developed countries and even lower in developing countries. Improving treatment adherence remains an almost universally agreed-upon challenge in health care.
Because much of the care needed for chronic conditions is based on patient self-management, monitoring and lifestyle changes, patients face several potentially life-threatening risks if not appropriately supported to adhere to their treatment plan.
For this reason, in 2016 Axios partnered with a large multinational pharmaceutical company operating in the UAE to develop and implement two innovative patient support programs focused on increasing adherence to treatment for patients diagnosed with Multiple Sclerosis, Psoriasis, Ankylosing Spondylitis, Psoriatic Arthritis or Asthma.
Understanding that no simplistic “one-size fits all” approach works, Axios supports each patient enrolled in these programs individually along their treatment journey through a multi-layered, personalized adherence plan that tackles the many barriers they, and their families, encounter daily as they strive to maintain optimal health.
Axios conducts a Needs Assessment with each patient, using Axios’ proprietary Patient Needs Assessment Tool (PNAT), to better understand their unmet needs across the 5 dimensions of adherence: social and economic, therapy related, patient related, healthcare team and system, and condition related dimensions.
A customized treatment plan is then created for the patient and their caregivers to encourage compliance to their treatment by helping them better manage their disease. Services offered by Axios to alleviate gaps in the patient’s treatment journey include disease education and psychological support through an on-demand support careline, disease education, patient and family support, disease monitoring support and quality of life services.
Since both programs were launched, more than 365 patients diagnosed with Multiple Sclerosis, Psoriasis, Ankylosing Spondylitis, Psoriatic Arthritis or Asthma, and their caregivers, across the UAE have benefited from personalized support and treatment plans.
In addition, health system accessibility, engagement and effectiveness has improved as a result of increased patient knowledge of available resources and improved treatment adherence.
- 12% of active patients faced insurance delays and rejections. After offering insurance follow up support, 100% of the patients offered the service are no longer face this challenge.
- 8% of active patients were scared of initiating treatment and 23% of active patients had concerns about chronic disease treatment duration. After hosting educational sessions about the disease and the medication with particular emphasis on the noted concerns, 92% of patients offered the service no longer face these challenges.
- 12% of active patients were scared of taking an injection. After conducting face-to-face meetings and detailed training on how to inject yourself, 100% of the patients offered the service no longer face this challenge.
 “Chronic diseases and health promotion”, WHO. Accessed 7th Aug 2017. http://www.who.int/chp/en/
 “Adherence to long-term therapies: Evidence for action”, WHO, January (2003). Accessed 7th Aug 2017. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf